Condition
FMD
Total Trials
6
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Completed5
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05747924Phase 1Completed
Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT06547216Phase 2Enrolling By Invitation
Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT05857085Phase 4Completed
Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
NCT04199949Not ApplicableCompletedPrimary
Effects of Five Days of Physical Inactivity on Endothelial Function in Healthy Humans
NCT02127333Completed
Role of Oxygen for Vascular Dysfunction
NCT01862146CompletedPrimary
Arterial Remodeling in Smokers
Showing all 6 trials